glp 1 who makes it GLP-1 medications have become one of the most talked-about topics in obesity medicine, but they're also surrounded by misinformation. In this carousel, I'm breaking down seven of the most common myths I 8-in-1 GLP-1 Supplement for Women

A pooled analysis of 3 longer-term RCTs 22,47,48 following 15,820 patients with T2DM up to 3.8 years showed a reduced risk of dementia for semaglutide and liraglutide compared with placebo 39

Researchers assessed one-year all-cause mortality outcomes in patients prescribed metformin alone or in combination with a GLP-1 receptor agonist

Results vary and take time

The clinical data tells a story of two fundamentally different approaches to the same problem, and the differences matter more than most comparison articles acknowledge

Propensity score matching To control for measured confounding, 1:1 propensity score matching without replacement was performed using a greedy nearest-neighbor algorithm with a caliper of 0.1 standard deviation of the logit of the propensity score